1981     Parrish, J.A., Momtaz, K, Paul, B.S., Tanghetti, E.A., and Stern, R.S.: MaximizingUltraviolet Phototherapy of Psoriasis. Psoriasis Proceedings of the third International Symposium.  Stanford University Grune & Stratton  413-414

1994    Tanghetti, E.A.: Head to Toe Dermatology, A Regional Approach to Practical Office Dermatology.  Sutter Community Hospitals of Sacramento

1995    Tanghetti, E.A.: Skin Cancer and its Benign Impersonators, Sutter Health.  Seventh Annual Dermatology Course

1995    Dierickx, C.C. et al, Chess, C. et al, Tanghetti, E.A. and Adrian, R.M.:  Long Pulsed 532nm Laser Treatment of Port Wine Stains.  Poster presented as the American Academy of Dermatology Winter Meeting

1995    Adrian, R.M.; Tanghetti, E.A: Therapeutic Dermabrasion. Arch Dermatol Jul; 131(7):850

1996    Tanghetti, E.A.: Dermatology Therapeutic Hotline, Sutter,CHS.  Eighth Annual Dermatology Update

1997    Tanghetti, E.A., Adrian, R.M.: Clinical Evaluation of High-Energy Long-Pulse Ruby Laser for the Treatment of Unwanted Body Hair. Laser Surgery Medicine  9:166

1997    Tanghetti, E.A.: Head to Toe Dermatology, A Practical Approach for Primary Care.  Sutter Health

1998    Adrian, R.M. and Tanghetti, E.A.: Long Pulse 532-nm Laser Treatment of Facial Telangiectasias. Dermatology Surgery 24:71 – 74

1998    Adrian, R.M. and Tanghetti, E.A.: Long Pulse 532-nm Laser Treatment of Lower Extremity Telangiectasias. A Clinical and Histologic Study. Lasers in Surgery and Medicine  10:31

1998    Tanghetti, E.A. and Adrian, R.M.: Long Pulsed 532-nm Laser Treatment of Port Wine Stains. Lasers in Surgery and Medicine  10:36

 1998    Tanghetti, E.A. and Adrian, R.M.: Long Pulsed 532-nm Laser Treatment of Facial Telangiectasias. Lasers in Surgery and Medicine  10:45

 1998    Adrian, R.M. and Tanghetti, E.A.: Cutaneous Laser Resurfacing with the Ultrapulse 5000 CO2 Laser. A Clinical and Histological Study Poster Presented at ASLMS

 1998    Tanghetti, E.A.:  Head to Toe Dermatology, Practical Approaches for Primary Care. Sutter Health

 1999    Tanghetti, E.A. and the Tazoratene Stable Plaque Psoriasis Trial Study Group: An Observation Study Evaluating the Efficacy and Tolerability of Tazoratene 0.05% and 0.1% Gels, as Monotherapy and in Combination with Adjunctive Therapies, in Stable Plaque Psoriasis. American Academy of Dermatology Winter Meeting

 1999    Tanghetti, E.A.: Photographic Tracking Study of Tazarotene Treatment, Alone and in Conjunction With Mometasone Furoate Cream or Calcipotriene Ointment, in Mild – to – Moderate Plaque Psoriasis.  Poster Presented at American Academy of Dermatology Winter Meeting

1999    Tanghetti, E.A.: The Essentials of Dermatology, Sutter Health.  UCME Program for the Primary Care Physician

1999    Tanghetti, E.A.: Topical retinoids in the Treatment of Acne Vulgaris. Cutis Aug; 64(2 Suppl):8-20

2000   Leyden, J, Tanghetti, E.A., Ling, M., and Berson, D.:  Comparison of Tazarotene Monotherapy, Tazarotene Combination Therapies and Clindamycin Monotherapy in Acne Vulgaris.  The Tazarotene CLEAR Trial

2000   Tanghetti, E.A.: The Use of Refrigerated Air or Contact Cooling for the Treatment of Leg Veins with a 755nm 20 and 40 msec Laser. Lasers in Surgery and Medicine 12:112

2000   Tanghetti, E.A.: Optimizing Acne Therapy With Topical Retinoids.  Skin & Allergy News  7:9-10

2000   Tanghetti, E.A.: Dermatology from Top to Bottom, Sutter Medical Center, Sacramento, CA.

2000   Tanghetti, E.A.: An Observation Study Evaluating the Treatment of Plaque Psoriasis with Tazarotene Gels, Alone with Emollient and/or Corticosteroid.  Cutis 66:4-11

2000   Tanghetti, E.A.: An Observation Study Evaluating the Efficacy of Tazarotene Plus Corticosteroid in Treating Plaque Psoriasis in Patients Switched From Treatment With Calcipotriene ± Corticosteroid.  Cutis  66:12-18

2000   Tanghetti, E.A.:  Efficacy and Tolerability of Once-Daily Tazarotene 0.1% Gel Versus Once-Daily Tretinoin 0.025% Gel In The Treatment of Facial Acne Vulgaris, A Randomized Trial.  Poster Presented to the Journal of the American Academy of Dermatology

2000   Tanghetti, E.A.:  Protocols in Practice, Management of Acne Vulgaris. 

2001    Tanghetti, E.A.:  Keller et al.  Lasers in Aesthetic Surgery  190-194

2001    Tanghetti, E.A.: Evaluation of Pulse Duration on Purpuric Threshold Using Extended Pulse Pulsed Dye Laser (Cynosure V-Star). Lasers in Surgery and Medicine 13S:105

2001    Tanghetti, E.A.; Adrian, R.M.: Treatment of Facial Telangiectasia with Single and Multiple Passess, Extended Pulse Width Pulsed Dye Laser (Cynosure V-Star) Lasers in Surgery and Medicine 13S:111

2001    Tanghetti, E.A.; Adrian, R.M.: A Clinical and Histological Study of a Pulse Diode 940nm Laser with Contact and Refrigerated Air Cooling for the Treatment of Abnormal Leg Veins Lasers in Surgery and Medicine 13S:269

2001    Tanghetti, E.A.Efficacy and Tolerability of Once-Daily Tazarotene 0.1% Gel Versus Once-Daily Tretinoin 0.025% Gel in The Treatment of Facial Acne Vulgaris, A Randomized Trial.  Cutis 67:4-9

2001    Sabbagh, L.; Tanghetti, E.A.: Pulsed Dye Laser Effective Tx for Facial Telangiectasia. Dermatology Times July:25

2001    Shalita, A.R., Leyden, J.L., Tanghetti, E.A., Kang, Sewon; Menter, MA; and Arndt, K.A.:  Innovations in Improving Facial Appearance, Abstracts and Selected Slides.

2002   Koo, J.Y., Lebwohl, M.G., Lowe, N.J., Menter, A., Tanghetti, E.A., and Shears, G.:  Optimizing Topical Retinoid Treatment of Psoriasis.  Skin & Allergy News

2002   Leyden, J., Tanghetti, E.A., Miller, B., Ling, D., Berson, D, and Lee, J: Cost Effectiveness of Tazarotene 0.1 % Gel and Tretinoin 0.1% Microsponge in The Treatment of Facial Acne Vulgaris.  Poster Presented at the American Academy of Dermatology Winter Meeting 

2002   Leyden, J.; Tanghetti, E.; Ling, M.; Berson, D.; Miller, B.: Tazarotene o.1% Gel versus Tretinoin 0.1% Microsponge in Facial Acne Vulgaris: A Multicenter, Double-Blind, Randomized, Parallel-Group Study. Poster Presented at the American Academy of Dermatology Winter Meeting

2002   Leyden, J.J., Tanghetti, E.A., Miller, B., Long, M., Berson, D., and Lee, J.:  Once-Daily Tazarotene 0.1% Gel Versus Once-Daily Tretinoin 0.1% Microsponge Gel For the Treatment of Facial Acne Vulgaris, A Double Blind Randomized Trial.  Cutis
69 2S:12-19

2002   Draelos, Z.D. and Tanghetti, E.A.Optimizing the Use of Tazarotene for the Treatment of Facial Acne Vulgaris Through Combination TherapyCutis
69 2S:20-29

2002   Tanghetti, E.A.: Use of Topical Tacrolimus in Vitiligo. Poster

2002   Tanghetti, E.A.: Topical Tacrolimus Imporves Vitiligo; Adding Sunlight May Help Even More. Deramtology Times March:11-12

2002   Tanghetti, E.A., Alvarado, S.L., and Gillis, P.R.:  Comparison of Localized UVB Phototherapy Systems for High Dose Treatment of Stable Plaque PsoriasisLasers in Surgery Medicine  14:312 (Abstract presented at ASLMS Meeting Atlanta, GA.)

2002   Tanghetti, E.A.Multi-pass Treatment Photodamage Using the Pulse Dye Laser (Photogenica V-Star).  Lasers in Surgery and Medicine  14:313

2002   Tanghetti, E.A.The Effects of Multi-pass on Purpuric Threshold and Depth of Tissue Injury in Extended Pulse Dye Laser (Photogenica V-Star).  Lasers in Surgery and Medicine  14:122

2002   Tanghetti, E.A.:  Treatment of Leg Veins with Extended Pulse-width Pulse Dye Laser (Photogenica V-Star).  Lasers in Surgery and Medicine  14:126

2002   Tanghetti, E.A.: BClear Photoclearing System Addresses Inflammatory Skin Conditions. Aesthetic Buyers Guide July/August

2002   Guttman, C.; Tanghetti, E.A.: Tazarotene’s New Wrinkle. Dermatology Times November:30,33

2002   Tanghetti, E.A., Sierra, R.A., Sherr, E.A., and Mirkov, M.: Evaluation of Pulse-Duration on Purpuric Threshold Using Extended Pulse Pulsed Dye Laser (Cynosure V-Star). Lasers in Surgery Medicine 31:363-366

2002   Tanghetti, E.A.: Parisian Peel Plays Key Role in Leading Dermatology Practice. Aesthetic Buyers Guide September/October:11

2003   Tanghetti, E.A., and Guttman, C.:  Tweaks in Intervals Improve Pulsed Dye Laser Treatment of Vascular Lesions Multi-PassesDermatology Times  Vol 24, No. 2, 14 & 23

2003   Tanghetti, E.A.Tacrolimus Ointment 0.1% Produces Repigmentation in Patients With Vitiligo, Results of a Prospective Patient SeriesCutis  158-162

2003   Tanghetti, E.A., Sherr, E.A., and Alvarado, S.L.:  Multi-pass Treatment of Photodamage Using the Pulse Dye LaserDermatologic Surgery  29:686-690

2003   Tanghetti, E.A. and Gillis, P.R.:  Clinical Evaluation of B-Clear and Protopic Treatment for VitiligoLasers in Surgery and Medicine  15:37

2003   Tanghetti, E.A.More Effects of Double-Pass Intervals on Purpuric Threshold and Depth of Tissue Injury in Extended Pulse Dye Laser (Photogenica V-Star).  Lasers in Surgery and Medicine  15:27

2003   Tanghetti, E.A.Extended Pulse Format Dye Laser and its Effects on Therapeutic EfficacyLasers in Surgery and Medicine  15:29

2003   Tanghetti, E.A.Dye Laser Extended Pulse Format Effects on Purpuric ThresholdLasers in Surgery and Medicine  15:273

2003   Tanghetti, E.A.Comparison of Pulse Dye Laser (PDL) and Intense Pulse Light (IPL) Source for the Treatment of  PhotodamageLasers in Surgery and Medicine  15:274

2003   Tanghetti, E.A.Combined Extended Pulse-Duration Dye Laser/Drug Therapy for Active Acne LesionsLasers in Surgery and Medicine  15:275

2003   Tanghetti, E.A.:  Hot Spots in Dermatology.  Catholic Healthcare West 

2003   Tanghetti, E.A., and Sherr, E.A.:  Treatment of Telangiectasia Using the Multi-Pass Technique with the Extended Pulse Width, Pulsed Dye Laser (Cynosure V-Star).  Journal of Cosmetic and Laser Therapy  Vol 5 No. 2, 71-75

2003   Tanghetti, E.A. and Gillis, P.R.:  Photometric and Clinical Assessment of Localized UVB Phototherapy Systems for the High-Dosage Treatment of Stable Plaque PsoriasisJournal of Cosmetic and Laser Therapy  Vol 5 No. 2, 101-106

2004   Tanghetti, E.A; Ambramovits, W.; Anderson, D.N.; Leonardi, C.L.; Leyden, J.J.: Next Generation Retinoids: Selectivity Implications. Skin & Allergy News Supplement

2004   Baumann, L., Goldman, M., Lupo, M., and Tanghetti, E.A.Experts Define the Role of Tazarotene in Anti-Aging Skin Treatment RegimensAesthetic Buyers Guide Clinical Roundtable

2004   Tanghetti, E.A. and Werschler, P.:  5% 5-Flourouracil Cream Versus 5% Imiquimod Cream in the Management of Actinic Keratoses: Real World ExperiencePoster Presented to the American Academy of Dermatology Meeting

2004   Tanghetti, E.A.; Cunningham, B.B.; Jeffes, E.W.B.; Katz, B.E.; Skidmore, R.A.; Torres, A.; Werschler, W.P.: Clinical Dialogues: Actinic Keratosis and Other Nonmelanoma Skin Cancers. Skin & Allergy News Supplement

2004   Lowe, N.J.; Kang, S.; Tanghetti, E.A.; et al: Tazarotene 0.1% Cream versus Tretinoin 0.05% Emollient Cream in the Treatment of Photodamaged Facial Skin, A Multi-Center, Double-Blind, Randomized, Parallel-Group Study. Poster Presented at the American Academy of Dermatology Meeting.

2004   Nanni, C.; Tanghetti, E.A.: Treatment of Tattoos with Single and Double-Pulse Q-Switched Alexandrite Laser. Lasers in Surgery and Medicine Vol 16:228 and Poster

2004   Tanghetti, E.A.: Pulse Dye Laser Treatment of Photo-Aging with and without Concurrent Tazarotene 0.1% Cream Therapy. Lasers in Surgery and Medicine Vol 16:252 and Poster

2004   Lowe, N.J., Gifford, M., Tanghetti, E,A., Poulin, Y.P., Goldman, M., Tse, Y., Yamauchi, P., Rosenzweig, H. and Kang, S.:  Tazarotene 0.1% Cream Versus Tretinoin 0.05% Emollient Cream in the Treatment of Photodamaged Facial Skin, A Multi-Center, Double-Blind, Randomized, Parallel-Group StudyJournal of Cosmetic and Laser Therapy Vol 6 No. 2, 79-85

2004   Anderson, D.N., Callender, V.D., Del Rosso, J.Q., Tanghetti, E.A., and Zane, L.T.:  Topical Tazarotene in Acne Vulgaris, Treatment ApproachesCutis  Vol 74 16-21

2004   Tanghetti, E.A.: A Critical Look at Our Therapy Options for Actinic Keratosis, Psoriasis, and Warts. Cosmetic Dermatology 11 S3 17:2

2004   Tanghetti, E.A.: Comparison of 5-Flourouracil 5% and Imiquimod 5% for Acitinic Keratosis. Cosmetic Dermatology 11 S3 17:16-20

2005   Kang, S., Krueger, G.G., Tanghetti, E.A., Lew-Kaya, D., Sefton, J., Walker, P., and Gibson, J.R.:  A Multicenter, Randomized, Double-Blind Trial of Tazarotene 0.1% Cream in the Treatment of PhotodamageJournal of American Academy of Dermatology  Vol 52 No. 2 268-274

2005   Tanghetti, E.A: Cynergy Workstation Utilizes Dual Wavelength Tx. Aesthetic Buyers Guide March/April: 1,5

2005   Tanghetti, EA, Sherr, E, Sierra, R, Mirkov, M: Sequential 595nm, 1064nm Laser Treatment for Blebbed Portwine Stains and Leg Veins. Lasers in Surgery & Medicine Suppl 17:249

2005   Tanghetti, E.A., Berson, D.S., Gold, M.H., Lupo, M.P. and Solomon, B.A.:  Acne Vulgaris and Rosacea, Optimizing TherapySkin & Allergy News

2005   Tanghetti, E.A., Webster, G.F., Del Rosso, J.Q. and Callender, V.D.:  Combination Therapy is the Standard of CareCutis  Vol 76 3, 8-14

2005   Tanghetti, E.A.: The Importance of the Vehicle in Protecting the Skin Barrier and Maximizing the Benefits of Acne Therapy. Skin & Aging Aug:75-77

2005   Tanghetti, E.A.:  The Use of Topical Retinoids with Combination Therapies in the Management of Acne Vulgaris, Maximizing Results in the Treatment of Acne and Improving Facial Appearance.   Skin & Allergy News  6-7

2005   Adrian R, Tanghetti E, Kauvar ANB Long Pulsed KTP Lasers in: Kauvara ANB ed Principles and Practices of Cutaneous Laser Surgery. New York Taylor & Francis

2006   Willey, A., Anderson, R.R., Azpiazu, J.L., Bakus, A.D., Barlow, R.J., Dover, J.S., Garden, J.M., Kilmer, S.L., Landa, N., Manstein, D., Ross, E.V., Sadick, N., Tanghetti, E.A., Taghmai, D., and Zelickson, B.D.:  Complications of Laser Dermatologic SurgeryLasers in Surgery and Medicine  38:1-15

2006   Tanghetti, E.A., Sherr, E.A., Sierra, R., and Mirkov, M.:  The Effects of Pulse Dye Laser Double-Pass Treatment Intervals on Depth of Vessel CoagulationLasers in Surgery and Medicine  38:16-21

2006   Del Rosso, J.Q. and Tanghetti, E.A.The Clinical Impact of Vehicle Technology Using a Patented Formulation of Benzoyl Peroxide 5%/Clindamycin 1% Gel, Comparative Assessments of Skin Tolerability and Evaluation of Combination Use with a Topical RetinoidJournal of Drugs in Dermatology 5:160-164

2006       Tanghetti, E.A., Solomon, B., Loven, K., and Shalita, A.:  Tazarotene Versus Tazarotene Plus Clyndamycin/Benzoyl Peroxide in the Treatment of Acne Vulgaris, A Multi-Center, Double-Blind, Randomized Parallel-Group TrialJournal of Drugs in Dermatology  5:256-261

2006   Tanghetti, E.A.: Topical Retinoids: the Misplaced Key to Treating Photodamaged Skin. Cosmetic Dermatology 19:364-368

2006   Tanghetti, E.A.: The Importance of Vehicle and Skin Barrier Function in Acne Vulgaris. Skin & Allergy News Supplement June:3-5

2006   Tanghetti, E.A.: Open-Label Evaluation of 5% Benzoyl Peroxide/1% Clindamycin Gel Used in Combination with Tazarotene0.1% Cream and Oral Minocycline in the Treatment of Severe Acne Vulgaris. Poster Presented American Academy of Dermatology March

2006   Tanghetti, E.A.: Treatment Options for Vascular Lesions. Skin & Aging Supplement January:13-16

2006   Bikowski, J; Callender, V.D.; Del Rosso, J.Q.; Draelos, Z.D.; Tanghetti, E.A: Combining Clindamycin 1% Benzoyl Peroxide 5% Gel With Multiple Therapeutic Options. Cutis 78 2S:13-20

2006   Mirkov, M; Sherr, EA; Sierra, RA; Lloyd, JA; Tanghetti, EA; Analytical modeling of laser pulse heating of embedded biological targets: An application to cutaneous vascular lesions. Journal of Applied Physics 2006;99:114701.1-114701.15

2006   Lowe, N; Horwitz, S; Tanghetti, E; Draelos, Z; Menter, A: Tazaratene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: A multicenter, double-blind, randomized study. Journal of Cosmetic and Laser Therapy 8: 121-127

2006   Tanghetti, E.A. et al: Cynergy with Multiplex Provides Double Effect for Vascular Lesions. Aesthetic Buyers Guide Clinical Roundtable Supplement

2007   Adrian, RM; Tanghetti, EA: Multicenter Evaluation of Cynergy Multiplex Laser Treatment of Leg Veins. Lasers in Surgery & Medicine Suppl 19:77

2007   Tanghetti, E.A.; Weiss, R.: Multicenter Study of Microthermal Laser Treatment of Acne Scars. Lasers in Surgery & Medicine Suppl 19:112

2007   Wilson, F.; Biesman, B.; Katz, B.; Tanghetti, E.A.; Weiss, R.:Affirm Provides Persistent results without Maintenance Treatment. Aesthetic Buyers Guide March/April:4-7

2007   Tanghetti, E.A.; Werschler, W.P.: Comparison of 5% 5-Fluorouracil Cream and 5% Imiquimod Cream in the Management of Actinic Keratoses on the Face and Scalp. Journal of Drugs in Dermatology 6:144-147

2007   Tanghetti, E.A.: The Impact and Importance of Resistance. Cutis 80:3-9

2007       Tanghetti, E.A.: Improving Tolerability While Maintaining Efficacy: Practical Tips Skin & Allergy News Supplement July 1-2

 2007   Tanghetti, E.A.; Dhawan, S.; Torok, H.; Kircik, L.: Tazarotene 0.1 Percent Gel Versus Tretinoin 0.025 Percent Gel Plus Clindamycin 1 Percent Gel in the Treatment of Facial Acne Vulgaris. Dermatology Online J. Jul 13;13(3):1

2007   Tanghetti, E.A.; Dhawan, S.S.: Combined Effects of Benzoyl Peroxide 5%/Clindamycin 1% Gel with Tretinoin .025% Cream Compared to Use of 1% Clindamycin Gel, Tretinoin .025% Cream and 5% Benzoyl Peroxide Wash in the Treatment of Acne Vulgaris. Poster Presented in August at American Academy of Dermatology Meeting New York.

2007   Kronemyer, B.; Tanghetti, E.A.: MedLite C6 PhotoAcoustic Therapy Improves Acne Scars. Aesthetic Buyers Guide July/August:60

2007   Hilten, L.; Tanghetti, E.A.: The Practice Newsletter. Dermatology Times September:66

2008   Nash, K., Tanghetti, E.A.:  Fractional Lasers Retinoids, Varying Wavelengths Optimize ResultsDermatology Times  Vol 29, No. 1, 68

2008   Tanghetti, E.A., Kircik, L., Wilson, D., Dhawan, S.: Comparison of a Novel Solubilized Benzoyl Peroxide Gel with Benzoyl Peroxide/Clindamycin: A Multicenter, Investigator-Blind, Randomized Study. Poster Presented to the American Academy of Dermatology Meeting

2008   Tanghetti, E.A., Draelos, Z., Grimes, P., Dhawan, S., Gold, M., Kircik, L., Green, L., Moore, A., Cook-Bolden, F.: Moisturizer Use Enhances Facial Tolerability of Tazarotene 0.1% Cream Without Compromising Efficacy in Patients with Acne Vulgaris. Poster Presented 32nd Hawaii Dermatology Seminar

2008   Tanghetti, E.A.: Treatment of Photorejuvenation and Neck Laxity Using Sequential Emmisions of Wavelengths – A Clinical and Histological Study. Lasers in Surgery and Medicine 20:281

2008       Tanghetti, E.A.: Treatment of Photorejuvenation and Skin Laxity Using Sequential Emissions of Wavelengths-A Clinical and Histological Study. Poster Presenting to the American Society for Laser Medicine and Surgery

2008   Lloyd, J.; Tanghetti, E.A.: Comparison of Affirm 1320/1440 nm Versus 1320 nm For the Treatment of Acne Scars – A Clinical and Histological Study. Lasers in Surgery and Medicine 20:66

2008    Lloyd, J., Tanghetti, E.A.: Comparison of Affirm 1320/1440nm versus 1320nm for the Treatment of Acne Scars-A Clinical and Histological Study. Poster Presenting to the American Society for Laser Medicine and Surgery

2008   Tanghetti, E.A.; Kircik, L.; Wilson, D.; Dhawan, S.: Solubilized Benzoyl Peroxide Versus Benzoyl Peroxide/Clindamycin in the Treatment of Moderate Acne. Journal of Drugs in Dermatology Vol 7, No 6:534-538

2008   Thiboutot, D.; Shalita, A.; Swinyer, L.; Tschen, E.; Eichenfield, L.; Del Rosso, J.; Tanghetti, E.: Comparison of a 3-Step Acne System Containing Solubilized Benzoyl Peroxide Versus Benzoyl Peroxide/CLindamycin: A Multicenter Investigator-Blind, Randomized Study (6week analysis of interim Data). Poster presented to American Academy of Dermatology Chicago, IL

2008   Tanghetti, E.A.: The Evolution of Benzoyl Peroxide Therapy. Cutis 82 5S:3-11

2009   Antibiotic Use in Dermatology Dermatologic Clinics Chapter 27 A Current Review of Topical Benzoyl Peroxide: New Perspectives on Formulation and Utilization 1:17-24

2009   Dover, J.S.; Baumann, L.; Bikowski, J.; Callendar, V.D.; Kandula, M.; Lupo, M.; Tanghetti, E.A.: A Stepwise Approach to Melasma Management and Treatment Cosmetic Dermatology Vol 22 2:81-88

2009   Tanghetti, E.A.: The Role of Topical Vitamin D Modulators in Psoriasis Therapy Journal of Drugs in Dermatology Vol 8 8:s4-s8

2009      Kircik, L; Green, L; Thiboutot, D; Tanghetti, E; et al: Comparing a Novel Solubolized Benzoyl Peroxide Gel with Benzoyl Peroxide/Clindamycin: Final Data From a Multicenter, Investigator-Blind, Randomized Study JDD Vol 8 9:812-818

2009   Tanghetti, E.A.: Fixed-Combination Clindamycin 1% Benzoyl Peroxide 5% Hydrating Gel: A Flexible Component of Acne Management Cutis 84 5S:18-24

2010        Tanghetti, E.A.: Randomized Comparison of Tazarotene 0.1% Cream and Adapalene 0.3% Gel in Patient with at Least Moderate Facial Acne Vulgaris and Postinflammatory Hyperpigmentation (PIH). Poster presented to Maui Derm 2010.

2010    Tanghetti, E.A.; Dhawan, S.; Green, L.: Randomized Comparison of the Safety and Efficacy of Tazarotene 0.1% Cream and Adapalene 0.3% Gel in the Treatment of Patients with at Least Moderate Facial Acne Vulgaris. JDD  9:549-558

2010    Harper, J.; Oefelein, M.; Tanghetti, E.A.: The Efficacy and Tolerability of Dapsone 5% Gel in Female Versus Male Patients withFacial Acne Vulgaris: Gender as a Clinically Relevant Outcome Variable. Poster presented to Fall Clinical Dermatology 2010

2010    Tanghetti, E.A. et al.: Pushing the Spectrum Optimizing Treatment of Vascular and Pigmented Lesions. Dermatology Times Suppl. Dec 2010

2011     Tanghetti, E.A.; Oefelein, M.: Unexpected Benefits of Topical Dapsone or Clindamycin/Benzoyl Peroxide in Combination with a Retinoid in the Treatment of Comedonal Acne. Poster presented to AAD February 2011

2011     Tanghetti, E.A.:Pathogenesis of Psoriasis: Emerging Research, The Emerging Role of Vitamin D in Dermatology. PVupdates print/online presentation www.pvupdate.com/GKS2.

2011     Raulin, C.; Karsai, S. (eds): Laser and IPL Technology in Dermatology and Aesthetic Medicine, DOI: 10.1007/978-3-642-03438-1_16 Springer-Verlag Berlin Heidelberg 2011 Chapter 16 Common Vascular Lesions 227-240

2011     Weiss, RA; Ross, EV; Tanghetti, EA; et al: Characterization of an Optimized Light Source and Comparison to Pulsed Dye Laser for Superficial and Deep Vessel Clearance. Lasers in Surg and Med 43:92-98.

2011     Tanghetti, E.A.: Lasers with non-Device Skin Treatment Interventions. ASLMS 2011 Annual Conference Fundamentals Course, Grapevine, TX

2011     Tanghetti, E.A.: Split-Faced Randomized Treatment of Facial Telangiectasia Comparing Pulsed Dye Laser and a New Optimized Light Handpiece. 31st Annual ASLMS Conference Presentation, Grapevine, TX

2011     Tanghetti, M.D.: Laser Hair Removal for Diverse Population with a Muti-plexed Dual Wavelength Device. 31st Annual Conference ASLMS Poster

2011         Tanghetti, E.A. et al: Clinical Evidence for the Role of a Topical Anti-Inflammatory Agent in Comedonal Acne: Findings From a Randomized Study of Dapsone Gel 5% in Combination with Tazarotene Cream 0.1% in Patient with Acne Vulgaris JDD Vol 10 7:783-792.

2012         Tanghetti, E.A.: Split-Face Randomized Treatment of Facial Telangiectasia Comparing Pulsed Dye Laser and an Intense Pulsed Light Handpiece. LSM 44:97-102

2011         Tanghetti EA, Callendar VD, Daniels SR, et al: Understanding Adult Women with Acne:A Web-Based Survey Assessing Burden of Acne in Adult Women. Poster Maui Derm 2012

2012         Callendar VD, Daniels SR, Tanghetti EA, et al: Treatment satisfaction and psychosocial impact of acne in adult women. Poster NADNP 2012

2012         Bikowski, J, Harper JC, Tanghetti EA, et al: Therapeutic Advances in the Topical Management of Acne. Practical Dermatology July 2012 Sup

2012         Baldwin HE, Daniels SR, Kawata AK, Burk CT Wilcox TK, Tanghetti EA: Acne Vulgaris in Adult Females: Healthcare Resource utilization for Treatment of Facial Acne. Poster Presented Fall Clinical 2012

2012         Tanghetti EA, Harper JC, Oefelein MG: The Efficacy and Tolerability of Dapsone 5% Gel in Female vs Male Patients with Facial Acne Vulgaris: Gender as a Clinically Relevant Outcome Variable. JDD Vol 11 12:1417-1421.

2013         Del Rosso JQ, Gallo RL, Tanghetti EA, Webster G, Thiboutot D: An Evaluation of Potential Correlations Between pathophysiologic Mechanisms, Clinical manifestations, and Management of Rosacea. Cutis Vol 91 3S:1-8

2013         Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 1: A Status Report on the Disease State, General Measures, and Adjunctive Skin Care. Cutis Vol 92:234-240

2013         Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 2: A Status Report on Topical Agents. Cutis Vol 92:277-284

2013         Del Rosso JQ, Tanghetti, EA: A Status Report on Topical Tazarotene in the Management of Acne Vulgaris. JDD Vol 12;3:S53-s58

2013         Tanghetti EA, et al: The Use of Topical 5-FU to Diagnose Subclinical Actnic Keratosis that Remain 3 Months after Three Different Actinic Keratosis Treatment Protocols. Poster Presented AAD March 2013

2013         Tanghetti EA:The Role of Inflammation in the Pathology of Acne JCAD September 2013 Vol 6 91:27-35

2014 Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 3: A Status Report on Systemic Therapies. Cutis Vol 93 1:18-28

2014         Tanghetti EA, et al. Understanding the Burden of Adult Female Acne. JCAD February 2014 Vol 7 2:22-30

2014         Tanghetti EA,et al. Consensus Recommendations from the American Acne & Rosacea Society on the Management of Rosacea, Part 4: A Status Report on Physical Modalities and Devices. Cutis Vol 93:71-76

2014         Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 5: A Guide on the Management of Rosacea. Cutis Vol 93:134-138

2015         Tanghetti EA, et al. Optimizing the Use of Topical Brimonidine in Rosacea Management: Panel Recommendations JDD January 2015 Vol. 14 33-40

2015         Tanghetti EA, et al. Impact of Female Acne on Pattern of Health Care Resource Utilization JDD February 2015 Vol. 14 140-148

2015         Tanghetti, EA, et al. A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines. ASDS November 2015 41:1310-1319

2015         Tanghetti EA, Hamann C, Tanghetti M, A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis. JDD Vol 14:11 1241-1244

2015         Weiss J, Stein L, Leoni M, Rueda MJ, Liu H, Tanghetti EA, Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parrallel-group, Controlled Study of a New Treatment-Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel. JDD Vol 14:12 1427-1435

2016         Stein Gold L, Weiss J, Rueda Jose M, Liu H, Tanghetti E, Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study. Am J Clin Dermatol 2016; 17(3):293-303

2016         Tanghetti, E.A.:. The Immediate Clinical and Thermal Findings Associated with the Use of a Picosecond Alexandrite laser With a Flat and A Fractional Optic. 2016 Annual ASLMS Conference Presentation/Abstract, Boston, MA

2016         Tanghetti, E.A.:.Comparative Cutaneous Histology From the Treatment Using a Picosecond Alexandrite and Nd:YAG Laser with a Fractional Options. 2016 Annual ASLMS Conference Presentation/Abstract, Boston, MA

2016         Tanghetti, E.A, Mirkov, M, Sierra, R.A. Delivery of Light to the Skin Through Ablated Conduits. Lasers in Surgery and Medicine. 2016 (48):4

2016         Tanghetti, E.A., The Histology of Skin Treated with a Picosecond Alexandrite Laser and a Fractional Lens Array. Lasers in Surgery and Medicine. 2016;48(7): 646-52

2016         Tanghetti, E.A., Tartar, D.M., Comparison of the Cutaneous Thermal Signatures Over Twenty-Four Hours With a Picosecond Alexandrite Laser Using a Flat or Fractional Optic. JDD. 2016; 15 (11):611-616

2017         Tanghetti, E.A, Jennings, J. Clinical and histologic comparative study with a 755nm picosecond Alexandrite laser with a diffractive lens array and a 532nm/1064nm Nd:YAG with a holographic optic. Laser in Surgery and Medicine. Vol 49 (9)

2017         Tanghetti, E.A., Kircik, L., Baldwin, H., Harper, J., Fu, Y., Alvandi, N. Once-Daily Topical Dapsone Gel 7.5% Is More Effective in Females Regardless of Baseline Acne Lesion Count. Presented at: Clinical Dermatology Conference, October 12-15, 2017. Las Vegas, NV

2017         Siegel D, Tanghetti E, Brody N,Freeman M, Skov T, Petersen A, Clonier F Spelman L. Ingenol Mebutate 0.06% Gel for Field Treatment of Actinic Keratosis on 250 cm2 of Skin on Trunk and Extremities: A Randomized Dose-Finding Trial. Journal of Cutaneous Medicine. Vol 1;3: 128 – 140

2017        Short-pulsed laser for the treatment of tattoos, pigmented lesions, scars and rejuvenation. Tanghetti EA, Hoffmann KA, Hoffmann K. Semin Cutan Med Surg. 2017 Dec;36(4):148-154. doi: 10.12788/j.sder.2017.032

2017         Del Rosso JQ, Tanghetti EA, Baldwin HE, Rodriguez DA, Ferrusi IL.The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey. J Clin Aesthet Dermatol. 2017 Jun;10(6):17-31. Epub 2017 Jun 1

2018         Tanghetti, E., Jennings, J. A compartative study with a 755nm picosecond Alexandrite laser with a diffractive lens array and a 532nm/1064nm Nd:YAG with a holographic optic. Laser in Surgery and Medicine.  Vol 50 (1). 33-44

2018         Baumann L, Goldberg DJ, Stein Gold L, Tanghetti EA, Lain E, Kaufman J, Weng E, Berk DR, Ahluwalia G.Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.J Drugs Dermatol. 2018 Mar 1;17(3):290-298

2018         Del Rosso JQ, Stein Gold L, Johnson SM, Rueda MJ, Baldwin H, Lain EL, Landis M, Rendon M, Tanghetti E, Weiss J. Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin. J Drugs Dermatol. 2018 Mar 1;17(3):264-273

2018         Tanghetti, E., Dover, J., Goldberg,D., Dhawan,S., Luo, L., Berk, D., Ahluwalia, G., Alvandi,N. Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0%. J Drug Dermatol. 2018; 17(6): 621-626

2018         Stockton, T., Tanghetti, E.A, Lain, E., Zeichner, J., Alvandi, N. Clinical experience with once-daily dapsone gel, 7.5% monotherapy in patients with acne vulgaris. J Drug Dermatol. 2018; 17(6): 602-608.

2018         Stein-Gold, L.,Kircik, L., Draelos, Z., Werschler P., DuBois,J., Lain,E., Baumann, L., Goldberg,D., Kaufman, J.,Tanghetti, E.A., Ahluwalia, G.,  Alvandi,N.,  Weng, E., Berk, D Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials. J Drug Dermatol.

2018         Tanghetti,E.A., Harper, J., Baldwin,H., Kircik, L., Bai, Z., Alvandi,N. . Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females. J Drug Dermatol. 2018l 17(11) 1032-1038.

2019         Tan, J., Tanghetti,E., Baldwin, H., Stein Gold, L. Lain, E., The Role of Topical Retinoids in Prevention and Treatment of Atrophic Acne Scarring: Understanding the Importance of Early Effective Treatment. J Drug Dermatol. 2019 18(3) 255-264.